Pfizer Stock Tumbles On 'A Big Setback' In Obesity Treatment - Investor's Business Daily
- Pfizer Stock Tumbles On 'A Big Setback' In Obesity Treatment Investor's Business Daily
- Pfizer stock drops as it ends development of Ozempic rival Yahoo Finance
- Pfizer Sells Off After Discontinuing Weight Loss Drug The Wall Street Journal
- Pfizer drops oral obesity drug after seeing liver safety concern, focuses on less-convenient candidate FierceBiotech
- Pfizer scraps one weight loss drug in race to develop Ozempic rival Yahoo News
- View Full Coverage on Google News